Oxidative stress in immunocompetent patients with severe community-acquired pneumonia. A pilot study

Medicina Intensiva

Volumn 38, Issue 2, 2014, Pages 73-82

  Trefler, S ^a   Rodriguez A ^a,b   Martin Loeches I ^c   Sanchez, V ^b   Marin J ^a   Llaurado M ^a   Romeu, M ^b   Diaz E ^c   Nogues R ^c   Giralt, M ^c  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

2009 Influenza A H1N1 virus; Bacterial pneumonia; Community acquired pneumonia; Oxidative stress

Indexed keywords

ADULT; BACTERIAL PNEUMONIA; COMMUNITY ACQUIRED INFECTION; FEMALE; HUMAN; IMMUNOCOMPETENCE; MALE; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS; PILOT STUDY; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; VIRUS PNEUMONIA;

ADULT; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; IMMUNOCOMPETENCE; MALE; MIDDLE AGED; OXIDATIVE STRESS; PILOT PROJECTS; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84894240297     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2013.01.004     Document Type: Article

References (43)

1. Wu D., Cederbaum A.I. Alcohol, oxidative stress, and free radical damage. Alcohol Res and Health 2003, 27:277-284.
2. Stocker R., Keaney F. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004, 84:1381-1478.
3. Thérond P., Bonnefont-Rousselot D., David-Spraul A., Conti M., Legrand A. Biomarkers of oxidative stress: an analytical approach. Curr Opin Clin Nutr Metab Care 2000, 3:373-384.
4. Crimi E., Sica V., Williams-Ignarro S., Zhang H., Slutsky A.S., Ignarro L.J., et al. The role of oxidative stress in adult critical care. Free Radic Biol Med 2006, 40:398-406.
5. Goodyear-Bruch C., Pierce J.D. Oxidative stress in critically ill patients. Am J Crit Care 2002, 11:543-551.
6. Sies H. Oxidative stress: introduction. Oxidative stress oxidants and antioxidants 1991, 15-22. Academic Press, London. H. Sies (Ed.).
7. Halliwell B. Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol 2006, 141:312-322.
8. Lucas R., Verin A.D., Black S.M., Catravas J.D. Regulators of endothelial and epithelial barrier integrity and function in acute lung injury. Biochem Pharmacol 2009, 77:1763-1772.
9. Draganov D., Teiber J., Watson C., Bisgaier C., Nemzek J., Remick D., et al. PON1 and oxidative stress in human sepsis and an animal model of sepsis. Adv Exp Med Biol 2010, 660:89-97.
10. Abiles J., Pérez de la Cruz A., Castaño J., Rodríguez-Elvira M., Aguayo E., Moreno-Torres J., et al. Oxidative stress is increased in critically ill patients according to antioxidants vitamins intake, independent of severity: a cohort study. Crit Care 2006, 10:R146.
11. Braun J., Pein M., Djonlagic H., Dalhoff K. Production of reactive oxygen species by central venous and arterial neutrophils in severe pneumonia and cardiac lung edema. Intensive Care Med 1997, 23:170-176.
12. Nowak D., Zieba M., Zawiasa D., Rozniecki J., Krol M. Changes of serum concentration of lipid peroxidation products in patients with pneumonia. Monaldi Arch Chest Dis 1996, 51:188-193.
13. Katsoulis K., Kontakiotis T., Baltopoulos G., Kotsovili A., Legakis I.N. Total antioxidant status and severity of community-acquired pneumonia: are they correlated?. Respiration 2005, 72:381-387.
14. Duflo F., Debon R., Goudable J., Chassar D., Allaouchiche B. Alveolar and serum oxidative stress in ventilator-associated pneumonia. Br J Anaesth 2002, 89:231-236.
15. Nin N., Sánchez-Rodríguez C., Ver L.S., Cardinal P., Ferruelo A., Soto L., et al. Lung histopathological findings in fatal pandemic influenza A (H1N1). Med Intensiva 2012, 36:24-31.
16. López Cde H., Roca R.F., Daunis J.V. Neumonía y síndrome de distrés respiratorio agudo producido por el virus influenza A (H1N1). Med Intensiva 2009, 33:455-458.
17. Maeda H., Akaike T. Oxygen free radicals as pathogenic molecules in viral diseases. Proc Soc Exp Biol Med 1991, 198:721-727.
18. Akaike T., Noguchi Y., Ijiri S., Setoguchi K., Suga M., Zheng Y.M., et al. Pathogenesis of influenza virus-induced pneumonia: Involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci USA 1996, 93:2448-2453.
19. Jacoby D.B., Choi A.M. Influenza virus induces expression of antioxidant genes in human epithelial cells. Free Rad Biol Med 1994, 16:821-824.
20. Choi A.M., Knobil K., Otterbein S.L., Eastman D.A., Jacoby D.B. Oxidant stress responses in influenza virus pneumonia: gene expression and transcription factor activation. Am J Physiol 1996, 271:L383-L391.
21. Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44:S27-S72.
22. Rello J., Rodríguez A., Ibañez P., Socias L., Cebrian J., Marques A., et al. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care 2009, 13:R148.
23. Rodríguez A., Mendia A., Sirvent J.M., Barcenilla F., de la Torre-Prados M.V., Solé-Violán J., et al. Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock. Crit Care Med 2007, 35:1493-1499.
24. Madeddu G., Porqueddu E.M., Cambosu F., Saba F., Fois A.G., Pirina P., et al. Bacterial Community Acquired Pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era. Infection 2008, 36:231-236.
25. Bodi M., Rodríguez A., Solé-Violán J., Gilavert M.C., Garnacho J., Blanquer J., et al. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Disease Society of America Guidelines on survival. Clin Infect Dis 2005, 41:1709-1716.
26. Alpert J.S., Thygesen K., Antman E., Bassand J.P. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000, 36:959-965.
27. Thygesen K., Alpert J.S., White H.D. Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Eur Heart J 2007, 28:2525.
28. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: severity of disease classification system. Crit Care Med 1985, 12:818-829.
29. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonça A., Bruining H., et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996, 22:707-710.
30. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. SCCM/ESICM/ACCP/ATS/SIS 2001. SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003, 31:1250-1256.
31. Richard M.J., Portal B., Meo J., Coudray C., Hadjian A., Favier A. Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. Clin Chem 1992, 38:704-709.
32. Misra H.P., Fridovich I. The rol of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972, 247:3170-3175.
33. Cohen G., Dembiec D., Marcus J. Measurement of catalase activity in tissue extracts. Anal Biochem 1970, 34:30-38.
34. Wheeler C.R., Salzman J.A., Elsayed N.M., Omaye S.T., Korte D.W. Automated assays for superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase activity. Anal Biochem 1990, 184:193-199.
35. Goldberg D.M., Spooner R.J. Glutathione Reductase. Methods of enzymatic analysis 1983, vol. 3:258-265. Verlag Chemie, Dearfield Beach. 3rd ed.
36. Hissin P.J., Hilf R.A. fluorometric method for determination of oxidized and reduced glutathiones in tissues. Anal Biochem 1976, 74:214-226.
37. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006, 6:173-182.
38. Chakraborty S.P., Das S., Chattopadhyay S., Tripathy S., Dash S.K., Pramanik P., et al. Staphylococcus aureus infection induced redox signaling and DNA fragmentation in T-lymphocytes: possible ameliorative role of nanoconjugated vancomycin. Toxicol Mech Methods 2012, 22:193-204.
39. Meister A., Anderson M.E. Glutathione. Ann Rev Biochem 1983, 52:711-760.
40. Bowie N., Moynagh P.N., O'Neill L.A.J. Lipid peroxidation is involved in the activation of NF-kB by tumour necrosis factor but not interleukin-1 in the human endothelial cell line ECV304. J Biol Chem 1997, 272:25941-25950.
41. Dubois-Rande J.L., Artigou J., Darmon J.Y., Habbal R., Manuel C., Tayarani I., et al. Oxidative stress in patients with unstable angina. Eur Heart J 1994, 15:179-183.
42. McMurray J. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J 1993, 14:1493-1497.
43. Oda T., Takaaki A., Hamamoto T., Suzuki F., Hirano T., Maeda H. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 1989, 244:974-976.